Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.21% | 202.77 | 1.2% | $538.23m | |
| GILD | Gilead Sciences, Inc. | -0.90% | 75.62 | 0.9% | $479.42m | |
| BIIB | Biogen Inc. | -0.11% | 338.23 | 1.3% | $390.35m | |
| CELG | Celgene Corporation | 0.00% | 84.28 | 1.2% | $342.66m | |
| ILMN | Illumina, Inc. | 0.73% | 328.96 | 3.5% | $326.50m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.14% | 399.06 | 2.6% | $241.66m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.97% | 128.94 | 2.0% | $225.63m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.02% | 185.48 | 1.9% | $218.83m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.46% | 141.99 | 16.4% | $179.98m | |
| A | Agilent Technologies, Inc. | -0.37% | 67.21 | 1.5% | $160.39m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.06% | 106.07 | 4.4% | $146.21m | |
| LGND | Ligand Pharmaceuticals Incorporated | -3.73% | 203.01 | 23.3% | $122.43m | |
| VKTX | Viking Therapeutics, Inc. | -2.62% | 14.86 | 0.9% | $115.47m | |
| NKTR | Nektar Therapeutics | 0.24% | 50.59 | 5.6% | $107.97m | |
| EXAS | Exact Sciences Corporation | -2.06% | 66.05 | 25.3% | $105.10m |
Company Profile
Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. It operates through the United States and Europe geogrpahical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.